HRT Financial’s MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share MRDB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-16,926
Closed -$2K 3353
2024
Q2
$2K Buy
16,926
+325
+2% +$40 ﹤0.01% 2094
2024
Q1
$1K Hold
16,601
﹤0.01% 2189
2023
Q4
$0 Buy
16,601
+3
+0% ﹤0.01% 3253
2023
Q3
$1K Sell
16,598
-3
-0% ﹤0.01% 2288
2023
Q2
$3K Sell
16,601
-100
-0.6% -$18 ﹤0.01% 2268
2023
Q1
$4K Buy
16,701
+100
+0.6% +$33 ﹤0.01% 2314
2022
Q4
$5K Buy
+16,601
New +$6.48K ﹤0.01% 2276

HRT Financial's MRDB.WS Position: Q3 2024 in Review

HRT Financial sold out of MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share (MRDB.WS) in Q3 2024, closing a stake of 16,926 shares — an estimated $2K sold.

HRT Financial first reported a position in MRDB.WS in Q4 2022 and held it in 7 quarters. The position peaked at $5K in Q4 2022. 0 funds tracked by Wall St. Rank hold MRDB.WS as of Q3 2024.

  • HRT Financial reported no remaining MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 16,926 MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share shares in Q3 2024, an estimated $2K.
  • HRT Financial first reported a position in MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share in Q4 2022 and held it in 7 quarters.
  • HRT Financial's MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share position peaked at $5K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.